Denmark, oncology-based Pharmacosmos today announced that it has assumed the worldwide rights, excluding select Asia-Pacific ...

US pharma major Eli Lilly (NYSE: LLY) announced a significant expansion of its long-standing alliance with Purdue University, ...

N) today presented data from the Phase III REAL8 basket study, which showed that once-weekly Sogroya (somapacitan) was ...

Shine Technologies, a private nuclear fusion corporation based in Wisconsin, USA, has entered into a definitive agreement to ...

UK-based pharma major AstraZeneca (LSE: AZN) has started construction on a new manufacturing site for small molecule drugs in ...

New figures from European industry group EFPIA paint a stark picture of the growing divide in access to innovative medicines ...

American health officials have recommended temporarily halting the use of Ixchiq (chikungunya virus vaccine, live) in people ...

The UK’s BioIndustry Association (BIA) has publishes its 10-year Vision for the UK life science sector called “A Vision for ...

Sylentis, a wholly-owned subsidiary of Spanish drugmaker PharmaMar (MSE: PHM), announced top-line results from the SYL1801-II ...

US President Donald Trump sent shivers through the pharmaceutical industry as he vowed to dramatically reduce the high drug prices that have long been a feature of the US market.

A sustainable healthcare system requires holistic approaches. However, the counterproposal to the cost-control initiative, which was rejected by the people, demonstrates once again that the Swiss ...

US biotech PTC Therapeutics released mixed new data on its Phase II trial of PCT187 (votoplam) in Huntington’s disease. UK ...